ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00286416
Recruitment Status : Unknown
Verified January 2006 by Scripps Health.
Recruitment status was:  Recruiting
First Posted : February 3, 2006
Last Update Posted : November 7, 2006
Sponsor:
Information provided by:
Scripps Health